A Randomised, Double-Blind, Placebo-controlled, study to determine the effect of Abelmoschus esculentus (Okra) extract on endurance in recreational runners. - NI

Arjuna Natural Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

研究概览

暂无简介。

•Males and Females 25 to 40 years of age (1:1 ratio)
•Body Mass Index between from 18.5 to 24.9 kg/m2
•Being recreationally active – Habitual running for 30 min for at least 3 days in a week for the past 3 months.
•IPAQ vigorous activity not less than 720 MET minutes per week.
•Normotensive (seated, resting systolic blood pressure less than 140 mm Hg and diastolic blood
•pressure less than 90 mm Hg. Normal seated, resting heart rate (less than 90 beats per minute).
•Subjects who are willing to refrain from using protein, vitamin, mineral and herbal supplements for the study period.
•Ability to follow all instructions in the study protocol and be willing to give written
•informed consent.

•COVID positive in the past 6 months.
•Received any vaccinations in the past 6 months.
•Current use of prescription or over-the-counter medications or unwillingness or inability to discontinue use of these medications at least 4 weeks before beginning the study.
•Cardiovascular complications.
•Use of protein, vitamin, mineral, and herbal supplements 1 week before the study.
•Alcoholic (greater than 2 pegs(60ml)per day) and smoking (has not stopped within 3 months of the study)
•Medical problems that would be a direct physical limitation.
•Current treatment for depression, alcohol or substance abuse, or psychosis
•Women of childbearing age intending for pregnancy or are pregnant, breastfeeding, or willing to practice contraception.
•Any condition, including laboratory abnormalities, that in the opinion of investigator places the volunteer at an unacceptable risk or deems the volunteer not suitable for participation in the study.
•Subjects who are unwilling to abstain from consuming okra and any other dietary supplements and to maintain their normal training and dietary habits.
•Subjects who participated in a clinical trial for the past 3 months.
•Unwilling to provide written informed consent.

发起方